Regenxbio Inc Earnings

The next earnings date for Regenxbio Inc is November 5, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Regenxbio Inc Earnings

Report Date	Estimated Earnings Per Share
11/05/2025	$-1.30

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Regenxbio Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
07/30/2025	---	$0	100.00%
05/06/2025	Before Market	$0.12	-75.29%
02/25/2025	Before Market	$-1.01	6.86%
11/06/2024	After Market	$-1.17	-4.46%
08/01/2024	After Market	$-1.05	18.60%
05/08/2024	After Market	$-1.33	-5.56%
02/27/2024	After Market	$-1.43	-12.60%
11/08/2023	After Market	$-1.41	7.24%
08/02/2023	After Market	$-1.66	-20.29%
05/03/2023	After Market	$-1.53	0.65%
02/28/2023	After Market	$-1.38	-12.20%
11/03/2022	Before Market	$-1.75	-19.86%
08/03/2022	After Market	$-1.58	-3.27%
05/04/2022	After Market	$-1.79	-35.61%
03/01/2022	After Market	$6.67	41.61%
11/02/2021	After Market	$-1.37	-26.85%
08/09/2021	After Market	$-1.36	-21.43%
05/05/2021	After Market	$-1.20	6.25%
03/01/2021	After Market	$-1.24	-188.37%
11/04/2020	After Market	$0.43	142.57%
08/06/2020	After Market	$-0.91	-2.25%
05/07/2020	After Market	$-1.08	-24.14%
02/26/2020	After Market	$-0.72	-63.64%
11/05/2019	After Market	$-0.94	-32.39%
08/07/2019	After Market	$-0.04	93.44%
05/07/2019	After Market	$-0.89	-3.49%
02/27/2019	After Market	$0.11	132.35%
11/07/2018	After Market	$-0.56	-27.27%
08/08/2018	Before Market	$0.30	-75.61%
05/08/2018	After Market	$3.04	204.00%
03/06/2018	After Market	$-0.51	37.80%
11/08/2017	After Market	$-0.67	6.94%
08/08/2017	After Market	$-0.47	37.33%
05/09/2017	After Market	$-0.82	-7.89%
03/07/2017	After Market	$-0.74	1.33%
11/09/2016	After Market	$-0.69	-4.55%
08/09/2016	Before Market	$-0.55	-3.77%
05/05/2016	Before Market	$-0.41	-2.50%
03/03/2016	Before Market	$-0.20	41.18%
11/05/2015	Before Market	$-1.52	---

More About Regenxbio Inc

Website

https://www.regenxbio.com

Country

USA

Full Time Employees

353

REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's products in pipeline includes ABBV-RGX-314 for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other chronic retinal diseases; and RGX-202, which is in Phase III clinical trial for the treatment of Duchenne muscular dystrophy, as well as RGX-121 for the treatment of mucopolysaccharidosis type II. It also develops RGX-111 for the treatment of mucopolysaccharidosis type I, RGX-181 for the treatment of late-infantile neuronal ceroid lipofuscinosis type 2, and RGX-381 for the treatment of the ocular manifestations of CLN2 disease. In addition, the company licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies. Further, it has a collaboration and license agreement with AbbVie Global Enterprises Ltd. to develop ABBV-RGX-314 outside the United States. REGENXBIO Inc. was incorporated in 2008 and is headquartered in Rockville, Maryland.

“Regenxbio Inc Earnings” Can Refer to the Regenxbio Inc Earnings Date

Some people say “Regenxbio Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Regenxbio Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Regenxbio Inc Stock on the Earnings Date

If you own Regenxbio Inc stock (RGNX) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Regenxbio Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Regenxbio Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Regenxbio Inc Earnings

You can contact us any time if you would like to ask questions about Regenxbio Inc earnings or anything else related to the stock market.